🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,068 results for “Pharm” Clear

  1. Alogliptin and pioglitazone

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  2. Alogliptin and pioglitazone

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  3. Alogliptin and voglibose

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  4. Alyftrek 125 mg/50 mg/10 mg film-coated tablets, VX-121/VX-661/VX-561 Film-coated tablet

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 3 small molecule active

    1 trial

  5. Ambrisentan Viatris 5 mg film-coated tablets, Placebo de AMBRISENTAN VIATRIS 5 mg - composition: cellulose microcristalline; lactose monohydraté; silice colloïdale anhydre; stéarate de magnésium (vegetable origin); opadry II 85G94065 PINK; eau purifiée, TADALAFIL

    Pari Pharma GmbH

    Pulmonary arterial hypertension

    phase 3 small molecule active

    1 trial

  6. Amifampridine Phosphate

    CATALYST PHARMACEUTICALS, INC.

    Myasthenia Gravis, MuSK

    phase 3 small molecule terminated

    1 trial

  7. Amifampridine Phosphate

    CATALYST PHARMACEUTICALS, INC.

    Lambert Eaton Myasthenic Syndrome

    phase 3 small molecule completed

    2 trials

  8. Amifampridine Phosphate

    CATALYST PHARMACEUTICALS, INC.

    Myasthenia Gravis, Generalized

    phase 3 small molecule completed

    1 trial

  9. Amisulpride, DEXAMETHASONE PHOSPHATE, ONDANSETRON

    Pharma Mar S.A.

    post-operative nausea and vomiting in pediatric patients

    phase 3 small molecule active

    1 trial

  10. Amlitelimab, Amlitelimab, -, -, -, Amlitelimab

    Sanofi Pharma Bristol-Myers Squibb

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  11. Amlitelimab, Placebo, -, TACROLIMUS , PIMECROLIMUS , Amlitelimab

    Sanofi Pharma Bristol-Myers Squibb

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  12. Amlitelimab, Placebo, Amlitelimab, PIMECROLIMUS , -, TACROLIMUS

    Sanofi Pharma Bristol-Myers Squibb

    atopic dermatitis

    phase 3 small molecule active

    1 trial

  13. Amlodipine

    Takeda Pharmaceuticals International AG

    Hypertension

    phase 3 small molecule terminated

    1 trial

  14. Amlodipine

    China SXT Pharmaceuticals

    Essential Hypertension

    phase 3 small molecule active

    1 trial

  15. An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria

    Pharma Mar S.A.

    Primary Hyperoxaluria

    phase 3 other active

    1 trial

  16. Anagrelide Hydrochloride

    Takeda Pharmaceuticals International AG

    Essential Thrombocythemia (ET)

    phase 3 small molecule completed

    1 trial

  17. Angoron 150 mg/3 ml amp ενέσιμο διάλυμα, FLECARDIA Διάλυμα για ένεση/έχχυση

    Pharma Mar S.A.

    Cardioversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary artery disease without residual ischemia and an left ventricular ejection fraction > 35%

    phase 3 small molecule active

    1 trial

  18. Anterior Capsulotomy

    China SXT Pharmaceuticals

    Obsessive-Compulsive Disorder

    phase 3 other active

    1 trial

  19. Anti-PD-1 antibody drug named Serplulimab

    China SXT Pharmaceuticals

    Locally Advanced Rectal Cancer (LARC)

    phase 3 small molecule active

    1 trial

  20. Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg

    Takeda Pharmaceuticals International AG

    Major Depressive Disorder

    phase 3 small molecule completed

    3 trials

  21. Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)

    Takeda Pharmaceuticals International AG

    Hemophilia A

    phase 3 mab terminated

    1 trial

  22. Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)

    Takeda Pharmaceuticals International AG

    Hemophilia A

    phase 3 small molecule completed

    1 trial

  23. Apitox - pure honeybee toxin

    Apimeds Pharmaceuticals US

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  24. Apitox, purified honeybee toxin, lyophilized in saline

    Apimeds Pharmaceuticals US

    Osteoarthritis of the Knee

    phase 3 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources